NCT02257684 · Interventional trial
A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
Overall registry status Terminated
Phase 2
Conditions Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Delaware Valley sites
- Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory